SCHEMBL4933175

SCHEMBL4933175

CC(C)(C)c1ccc(C(C)(C)Cn2c(CCC(N)C(=O)NO)nc3ccccc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.42
HDAC1 Q13547 4/20 0.42
HDAC6 Q9UBN7 4/20 0.42
HDAC3 O15379 2/20 0.42
HDAC4 P56524 2/20 0.42
HDAC7 Q8WUI4 2/20 0.42
HDAC2 Q92769 2/20 0.42
HDAC10 Q969S8 2/20 0.42
HDAC11 Q96DB2 2/20 0.42
HDAC8 Q9BY41 2/20 0.42
HDAC9 Q9UKV0 2/20 0.42
HDAC5 Q9UQL6 2/20 0.42
TP53 P04637 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
POLB P06746 1/20 0.41
KDM4E B2RXH2 1/20 0.40
CYP2C9 P11712 1/20 0.39
ALDH1A1 P00352 1/20 0.39
RECQL P46063 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4933168 1.00 GAA (0.42) GAAHDAC1HDAC6HDAC3HDAC4
SCHEMBL4929046 0.88 TP53 (0.56) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL4929060 0.88 TP53 (0.56) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL4935060 0.88 HDAC1 (0.47) GAAHDAC1HDAC6POLBKDM4E
SCHEMBL4935071 0.88 HDAC1 (0.47) GAAHDAC1HDAC6POLBKDM4E
SCHEMBL4933304 0.80 LMNA (0.56) GAAHDAC1HDAC6POLBKDM4E
SCHEMBL4928835 0.80 MEN1 (0.56) GAATP53SMN1; SMN2POLBKDM4E
SCHEMBL4933291 0.80 LMNA (0.56) GAAHDAC1HDAC6POLBKDM4E
SCHEMBL4928842 0.80 MEN1 (0.56) GAATP53SMN1; SMN2POLBKDM4E
SCHEMBL4934445 0.79 SMN1; SMN2 (0.60) GAATP53SMN1; SMN2POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative KUREHA CORPORATION (JP) 2008-06-05 US disclosed
EP-1707560-A1 HYDROXAMIC ACID DERIVATIVE AND AGE GENERATION INHIBITOR CONTAINING THE DERIVATIVE Kureha Corporation (JP) 2006-10-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative HDAC5, HDAC1, HDAC9 GAA 107/4885HDAC1 2/4885HDAC6 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.